BrainsWay Ltd. (BWAY) Stock Analysis

Company Overview

BrainsWay Ltd. (BWAY) is capitalised at $568.94M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 129.

Over the past 52 weeks the price has ranged from $7.14 to $17.40. The most recent close on file for BWAY is $14.15, dated September 4, 2026. That is −$0.36 (−2.48%) against the previous close. The latest close sits 98.32% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $52.23M. Against the prior fiscal year total of $41.02M, that is a change of +27.33%. The same year closed with net income of $7.63M. That is +161.31% against the prior fiscal year. The reported profit margin is 15.56%. That is 17.2 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 0.22.

Across the 4 fiscal years on file, revenue moves from $27.18M in 2022 to $52.23M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

BWAY trades at a trailing price-to-earnings ratio of 64.32. That is 140% above the Medical Devices median of 26.8. The forward P/E on file is 27.93. Measured against sales, the shares trade at 9.37 times revenue. On price-to-sales that is 3.1 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Beta against the wider market is reported at 0.08. Annualized volatility over the trailing 7 years is 62.2%. The trailing one-year price return is +77.21%. Measured over 5 years, that is +28.75% a year compounded.

Growth & Income

The record shows no dividend for BWAY.

2026 is still running; the price is +48.79% year to date. The strongest complete calendar year on file is 2023 at +162.35%; the weakest is 2022 at −67.92%. Of the 6 complete calendar years on file, 4 finished higher.